Citius Oncology Inc banner
C

Citius Oncology Inc
NASDAQ:CTOR

Watchlist Manager
Citius Oncology Inc
NASDAQ:CTOR
Watchlist
Price: 0.703 USD 8.47% Market Closed
Market Cap: $62.1m

Wall Street
Price Targets

CTOR Price Targets Summary
Citius Oncology Inc

Wall Street analysts forecast CTOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
762% Upside
Average
Price Target
6.12 USD
771% Upside
Highest
Price Target
6.3 USD
796% Upside
Citius Oncology Inc Competitors:
Price Targets
LAND
Gladstone Land Corp
13% Upside
WASH
Washington Trust Bancorp Inc
6% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTOR's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett